Navigation Links
Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
Date:8/19/2007

BASINGSTOKE, England and PHILADELPHIA, August 15 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces that the waiting period under Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to its exclusive license of JUVISTA(R) (human TGF BETA 3) from Renovo Group plc (LSE: RNVO) expired on August 10, 2007. In accordance with its terms, the License Agreement became effective on August 15, 2007.

JUVISTA is a novel biopharmaceutical investigational drug and when injected at the time of surgery has been shown in clinical trials to markedly improve subsequent scar appearance in the skin.

Under the terms of the agreement, Shire has the exclusive right to commercialize JUVISTA worldwide, with the exception of EU member states. Shire's financial obligations under the agreement are geared to JUVISTA's successful development and commercialization. Shire will now pay Renovo US$75 million upfront (expensed during the third quarter as R&D for US GAAP purposes) and in addition, Shire will make an equity investment in Renovo of US$50 million (at a subscription price of GBP2 per share, which represents approximately 6.5% of Renovo's share capital immediately after the issue).

On the FDA's acceptance of filing of JUVISTA's biologics license application, Shire will pay US$25 million and on FDA approval, between US$50 and US$150 million depending on the characteristics of the approved product labelling. Shire will also pay Renovo royalties on sales of JUVISTA and milestone payments of up to US$525 million on the achievement of very significant sales targets.

Notes to Editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestina
'/>"/>

SOURCE Shire PLC

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Im Still Waiting for the Information Age in Healthcare

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...signC or p.(IDC)announcedtodaythatDr.BruceL.A.Cart...cessfultrackrec or dinbiotechnologyexecutivemanage...netics,inSeattle,WAandChiefScientificOfficeratNovo.../www.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...ficercommented,"IamdelightedtowelcomeDr.BruceCarte...
(Date:11/23/2009)...l/--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),asp...elopingandcommercializingsignificantproductsprimar...edthatCraigA.Collard,PresidentandChiefExecutiveOff...nualPiperJaffrayHealthCareConferenceat3:30PMETonWe...YorkCity. ,, AliveaudioandarchivedwebcastofCorn...
(Date:11/20/2009)...stCall/ -- Dendreon Corporation (Nasdaq: DNDN ) t...tration (FDA) provided written acknowledgement tha...ion (BLA) for PROVENGE® (sipuleucel-T) is a c...tion Drug User Fee Act (PDUFA) date of May 1, 2010...ded BLA. Dendreon is seeking licensure for PROVEN...
(Date:11/20/2009)...ently announced that a free webinar, “Roller...rticle Characterization”, will be presented ...tion of in situ particle characterization is demon...ies of roller compaction runs while varying raw ma... , (PRWEB) November 20, 2...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2
... the advanced steam methane reforming reactor, whe...process. Mark Baffa looks at core of the reacto.... Modine Manufacturing Co. and ChevronTexaco T...National Hydrogen Association conference in Washin...tract hydrogen from natural gas. , ,Modine, a firm...
... creative idea or invention, or you are interested...t to protect, the first thing you do is contact a ... believe that you have protected your invention, s...ventors and entrepreneurs should heed Mom,s sage a... and know where you are going before you start on ...
...onic Foundry Inc. has added five universities to t... that use its Mediasite rich media system to power...ty of Colorado College of Engineering and Applied ...ity-Purdue University Fort Wayne, Northwestern Uni...ned on as new customers. , ,Mediasite is a record...
Other Biology Technology:Modine Manufacturing makes hydrogen generator with ChevronTexaco 2Modine Manufacturing makes hydrogen generator with ChevronTexaco 3Modine Manufacturing makes hydrogen generator with ChevronTexaco 4Five patent tips for start-up companies 2Five patent tips for start-up companies 3Sonic Foundry gains five university clients for Mediasite 2
(Date:11/23/2009)...ersity of Southern California biomedical engineer ...op a new tool to help clinicians distinguish cardi...ronic problems manageable with drugs and lifestyle...inserted into the arteries feeding the heart, offe... of these blood vessels, often revealing deposits ...
(Date:11/23/2009)...ians like frogs and toads have existed for 360 mil... but a new aquatic fungus is threatening to make m...e November issue of Microbiology Today . , The...s found to be associated with waves of amphibian e...stralia in the 1990,s. Bd infects over 350 amphibi...
(Date:11/23/2009)...tional Institute of General Medical Sciences (NIGM...), is investing $42.3 million for grants in scient...GO)." NIH developed the GO grant program to stimul...s provided by the American Recovery and Reinvestme...jects that promise to have a significant impact on...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3New Polls Reports Highlight The Need To Update The U S Food Safety System And To Make Our Food Safe For The Holidays 61258 1New Polls Reports Highlight The Need To Update The U S Food Safety System And To Make Our Food Safe For The Holidays 61258 2New Polls Reports Highlight The Need To Update The U S Food Safety System And To Make Our Food Safe For The Holidays 61258 3Mesa Labs Increases Quarterly Dividend 61255 1Reid Moves Toward Progressive Financing Measure to Help Fund Health Care Reform 61252 1Reid Moves Toward Progressive Financing Measure to Help Fund Health Care Reform 61252 2
...gists at the EPFL (Ecole Polytechnique Federale de...c pathway that cells use to defend themselves agai...e discovery of this pathway, published in the Sept...nderstanding of how cells mount a survival respons... gives insight into the more general process of ce...
...e University researchers have developed a biochip ...nd is capable of obtaining 60 times more data in j...nology. , In the near term, the biochip could spe...g development for muscle and nerve disorders like ...eties. , "Instead of doing one experiment per ...
...hourly levels of air pollution, more than double t...ublished ahead of print in Occupational and Enviro...tory and cardiovascular problems tends to be linke...ther than variations in hourly levels. , The rese...ged 65 years and older, occurring between January ...
Other Biology News:A new understanding of how cells defend themselves against bacterial pore-forming toxins 2A new understanding of how cells defend themselves against bacterial pore-forming toxins 3New biochip helps study living cells, may speed drug development 2New biochip helps study living cells, may speed drug development 3
Canine IL-10 ELISA Kit from R&D Systems
Mouse Anti-Human COMPLEMENT SC5B-9 (NEOANTIGEN) Monoclonal Antibody, Unconjugated, Clone 3R2/0 from AbD Serotec
Rabbit Anti-NEOPTERIN Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: